Paraic A Kenny

9PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 14, 2026
Analytical Validation of Multimodal AI Test Predicting Breast Cancer Recurrence Risk (Ataraxis Breast RISK).

Marc Dantone, Martin Lacsamana, Ken G Zeng

|Dec 23, 2023
Grb7 knockout mice develop normally but litters born to knockout females fail to thrive.

Kristopher A Lofgren, Paraic A Kenny

|Sep 16, 2022
Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate.

Kristopher A Lofgren, Nicolette C Reker, Sreeja Sreekumar

|Dec 08, 2021
Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer.

Kristopher A Lofgren, Sreeja Sreekumar, E Charles Jenkins

|Dec 16, 2019
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice.

David R Meier, Megan A Girtman, Kristopher A Lofgren

Pageof 2